WEKO3
アイテム
{"_buckets": {"deposit": "66cb9063-2414-446c-be5d-77e50c5805c0"}, "_deposit": {"created_by": 1, "id": "72104", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "72104"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00072104", "sets": ["28"]}, "author_link": ["710065", "710076", "710068", "710078", "710070", "710067", "710077", "710066", "710074", "710064", "710063", "710072", "710073", "710069", "710075", "710079", "710071"], "item_10005_date_7": {"attribute_name": "発表年月日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2012-08-10", "subitem_date_issued_type": "Issued"}]}, "item_10005_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Objectives: Dopamine synthesis rate, one of the presynaptic functions of the central dopaminergic\nsystem, can be measured by positron emission tomography (PET) measurement with L-[β-11C]DOPA\n[1]. The radiolabeled O-methyl metabolite of L-[β-11C]DOPA in peripheral organ, L-[β-11\nC]O-methyl-DOPA (L-[β-11C]OMD), suggested to penetrate the blood-brain barrier (BBB). Thus, L-[β-\n11C]OMD may affect tissue radioactivity measured by PET and the endogenous dopamine synthesis rate\nestimated by kinetic analyses. However, the influence of L-[β-11C]OMD in the living tissue for the\nkinetic analyses has not been investigated in detail. In the present study, to evaluate the influence of\nL-[β-11C]OMD on the tissue time-activity curve (TAC) with L-[β-11C]DOPA PET, the metabolite\ncorrection was applied to tissue TACs acquired from healthy volunteers.\nMethods: The metabolite correction method proposed by Kumakura et al. in [18F]FDOPA PET study\n[2] was employed. In this method, component for O-methyl metabolite in the tissue TAC is estimated by\ncompartmental analysis with two kinds of arterial input function for L-[β-11C]DOPA and L-[β-11\nC]OMD, and TAC in occipital cortex as a reference region with no irreversible binding. TAC in each\nbrain region for L-[β-11C]DOPA PET studies with ten healthy volunteers [1] was corrected by using the\nestimated L-[β-11C]OMD TAC. This method assumes the distribution of O-methyl metabolite is\nuniform around the brain [3].\nThe endogenous dopamine synthesis rate (Ki) was estimated by Gjedde-Patlak plot analysis with the\narterial input function and the metabolite-corrected TAC. The Ki was also estimated from the\nnon-corrected TAC. For comparison to conventional analysis, relative influx constant (kref) was also\nestimated by Gjedde-Patlak plot analysis using TAC in occipital cortex, regarded as reference tissue\ninput function. Data of 29 – 64 min and 29 – 89 min were used for linear regression in Gjedde-Patlak\nplot analysis.\nResults: Calculated OMD component had only a marginal effect on tissue TAC (fraction of area under\ncurve (AUC) of L-[β-11C]OMD TAC in putaminal TAC: 9.4 ± 2.1 %). Ki with no metabolite corrected\nTAC correlated significantly to Ki with the metabolite correction (p \u003c 0.001, r = 0.99 (29 – 64 min), p \u003c\n0.001, r = 0.99 (29 – 89 min)), and Ki were overestimated in all brain regions with no metabolite\ncorrection, see Figure A. kref also correlated to Ki with the metabolite correction, as shown in Figure B\n(p \u003c 0.001, r = 0.99 (29 – 64 min), p \u003c 0.001, r = 0.99 (29 – 89 min)).\nConclusion: The results suggest that the influence of the O-methyl metabolite L-[β-11C]OMD to tissue\nTAC and kinetic parameters in L-[β-11C]DOPA PET is marginal. This finding is accounted for by low\nfraction of L-[β-11C]OMD in plasma in case of L-[β-11C]DOPA, in contrast with high fraction of\nO-methyl metabolite for [18F]FDOPA. The results also suggest the net endogenous dopamine synthesis\nrate can be determined without the metabolite correction in case of L-[β-11C]DOPA, not same as [18\nF]FDOPA.\nReference\n[1] Ito H., et al., 2006, Nucl. Med. Commun. 27, 723-731\n[2] Kumakura Y., et al., 2005, J. Cereb. Blood Flow Metab. 25, 807-819\n[3] Doudet D.J., et al., 1991, J. Cereb. Blood Flow Metab. 11, 726-734\nNote - image will be printed in black \u0026 white", "subitem_description_type": "Abstract"}]}, "item_10005_description_6": {"attribute_name": "会議概要(会議名, 開催地, 会期, 主催者等)", "attribute_value_mlt": [{"subitem_description": "The Ninth International Symposium on Functional Neuroreceptor Mapping of the Living Brain", "subitem_description_type": "Other"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Matsubara, Keisuke"}], "nameIdentifiers": [{"nameIdentifier": "710063", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ito, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "710064", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ikoma, Yoko"}], "nameIdentifiers": [{"nameIdentifier": "710065", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Okada, Maki"}], "nameIdentifiers": [{"nameIdentifier": "710066", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Masanobu, Ibaraki"}], "nameIdentifiers": [{"nameIdentifier": "710067", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nakamura, Kazuhiro"}], "nameIdentifiers": [{"nameIdentifier": "710068", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamaguchi, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "710069", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Suhara, Tetsuya"}], "nameIdentifiers": [{"nameIdentifier": "710070", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kinoshita, Toshibumi"}], "nameIdentifiers": [{"nameIdentifier": "710071", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "松原 佳亮", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "710072", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "伊藤 浩", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "710073", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "生駒 洋子", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "710074", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "岡田 真希", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "710075", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "茨木 正信", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "710076", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "中村 和浩", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "710077", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "山口 博司", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "710078", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "須原 哲也", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "710079", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference object", "resourceuri": "http://purl.org/coar/resource_type/c_c94f"}]}, "item_title": "Correction for Radiolabeled O-Methyl Metabolite in Human Brain", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Correction for Radiolabeled O-Methyl Metabolite in Human Brain"}]}, "item_type_id": "10005", "owner": "1", "path": ["28"], "permalink_uri": "https://repo.qst.go.jp/records/72104", "pubdate": {"attribute_name": "公開日", "attribute_value": "2016-12-22"}, "publish_date": "2016-12-22", "publish_status": "0", "recid": "72104", "relation": {}, "relation_version_is_last": true, "title": ["Correction for Radiolabeled O-Methyl Metabolite in Human Brain"], "weko_shared_id": -1}
Correction for Radiolabeled O-Methyl Metabolite in Human Brain
https://repo.qst.go.jp/records/72104
https://repo.qst.go.jp/records/7210486c52139-e43b-4d53-9636-3dbcf37b24d6
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2016-12-22 | |||||
タイトル | ||||||
タイトル | Correction for Radiolabeled O-Methyl Metabolite in Human Brain | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Matsubara, Keisuke
× Matsubara, Keisuke× Ito, Hiroshi× Ikoma, Yoko× Okada, Maki× Masanobu, Ibaraki× Nakamura, Kazuhiro× Yamaguchi, Hiroshi× Suhara, Tetsuya× Kinoshita, Toshibumi× 松原 佳亮× 伊藤 浩× 生駒 洋子× 岡田 真希× 茨木 正信× 中村 和浩× 山口 博司× 須原 哲也 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Objectives: Dopamine synthesis rate, one of the presynaptic functions of the central dopaminergic system, can be measured by positron emission tomography (PET) measurement with L-[β-11C]DOPA [1]. The radiolabeled O-methyl metabolite of L-[β-11C]DOPA in peripheral organ, L-[β-11 C]O-methyl-DOPA (L-[β-11C]OMD), suggested to penetrate the blood-brain barrier (BBB). Thus, L-[β- 11C]OMD may affect tissue radioactivity measured by PET and the endogenous dopamine synthesis rate estimated by kinetic analyses. However, the influence of L-[β-11C]OMD in the living tissue for the kinetic analyses has not been investigated in detail. In the present study, to evaluate the influence of L-[β-11C]OMD on the tissue time-activity curve (TAC) with L-[β-11C]DOPA PET, the metabolite correction was applied to tissue TACs acquired from healthy volunteers. Methods: The metabolite correction method proposed by Kumakura et al. in [18F]FDOPA PET study [2] was employed. In this method, component for O-methyl metabolite in the tissue TAC is estimated by compartmental analysis with two kinds of arterial input function for L-[β-11C]DOPA and L-[β-11 C]OMD, and TAC in occipital cortex as a reference region with no irreversible binding. TAC in each brain region for L-[β-11C]DOPA PET studies with ten healthy volunteers [1] was corrected by using the estimated L-[β-11C]OMD TAC. This method assumes the distribution of O-methyl metabolite is uniform around the brain [3]. The endogenous dopamine synthesis rate (Ki) was estimated by Gjedde-Patlak plot analysis with the arterial input function and the metabolite-corrected TAC. The Ki was also estimated from the non-corrected TAC. For comparison to conventional analysis, relative influx constant (kref) was also estimated by Gjedde-Patlak plot analysis using TAC in occipital cortex, regarded as reference tissue input function. Data of 29 – 64 min and 29 – 89 min were used for linear regression in Gjedde-Patlak plot analysis. Results: Calculated OMD component had only a marginal effect on tissue TAC (fraction of area under curve (AUC) of L-[β-11C]OMD TAC in putaminal TAC: 9.4 ± 2.1 %). Ki with no metabolite corrected TAC correlated significantly to Ki with the metabolite correction (p < 0.001, r = 0.99 (29 – 64 min), p < 0.001, r = 0.99 (29 – 89 min)), and Ki were overestimated in all brain regions with no metabolite correction, see Figure A. kref also correlated to Ki with the metabolite correction, as shown in Figure B (p < 0.001, r = 0.99 (29 – 64 min), p < 0.001, r = 0.99 (29 – 89 min)). Conclusion: The results suggest that the influence of the O-methyl metabolite L-[β-11C]OMD to tissue TAC and kinetic parameters in L-[β-11C]DOPA PET is marginal. This finding is accounted for by low fraction of L-[β-11C]OMD in plasma in case of L-[β-11C]DOPA, in contrast with high fraction of O-methyl metabolite for [18F]FDOPA. The results also suggest the net endogenous dopamine synthesis rate can be determined without the metabolite correction in case of L-[β-11C]DOPA, not same as [18 F]FDOPA. Reference [1] Ito H., et al., 2006, Nucl. Med. Commun. 27, 723-731 [2] Kumakura Y., et al., 2005, J. Cereb. Blood Flow Metab. 25, 807-819 [3] Doudet D.J., et al., 1991, J. Cereb. Blood Flow Metab. 11, 726-734 Note - image will be printed in black & white |
|||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | The Ninth International Symposium on Functional Neuroreceptor Mapping of the Living Brain | |||||
発表年月日 | ||||||
日付 | 2012-08-10 | |||||
日付タイプ | Issued |